This suggests that CD8+ T cells are not critically involved in the antitumor effect of the Mix + GalCer approach in our model, despite having found a significant amount of tumor-specific IFN-γ secreting CD8+ T cells. The gene discussed is CD8A; the disease is neoplasm.